Background: Elderly patients with COVID-19 often exhibit a complex interplay between hypercoagulability and coagulopathy, key factors in determining the risk of severe complications and mortality. This study aimed to analyze coagulation and inflammatory markers to identify critical predictors of adverse outcomes in this vulnerable population. Material and Methods: The retrospective study was conducted on a sample of 1429 elderly patients (≥60 years) diagnosed with COVID-19, hospitalized in “Sf. Ap. Andrei” St. Apostle Andrew’s County Emergency Hospital in various wards between March 2020 and August 2022. Data were collected from medical records and included inflammatory markers (C-reactive protein, procalcitonin, ESR) and coagulation markers (prothrombin time, INR, fibrinogen, D-dimer). The SPSS 2.0 statistical software was used to conduct the study. Results:Coagulation markers: Prothrombin activity averaged 74.22%, below normal levels, indicating a heightened bleeding risk, while fibrinogen levels were significantly elevated (mean: 531.69 mg/dL), reflecting hypercoagulability. Prolonged prothrombin time (mean: 17.28 s) and elevated INR (International normalized ratio) (mean: 1.51) were associated with increased mortality, emphasizing their role in risk stratification. Elevated D-dimer levels (mean: 2.75 mg/L) further highlighted thromboembolic risks. Inflammatory markers: C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) showed marked elevations (mean CRP: 92.09 mg/L, mean ESR: 58.47 mm/h), correlating with heightened systemic inflammation and poor outcomes. Bacterial infections: Elevated procalcitonin (mean: 1.98 ng/mL) suggested secondary bacterial infections, particularly in mechanically ventilated patients, significantly worsening prognosis. Conclusions: The duality of hypercoagulability and coagulopathy in elderly COVID-19 patients underscores the importance of consistently monitoring coagulation markers such as prothrombin time, INR, D-dimer, and fibrinogen. Simultaneously, elevated inflammatory markers and secondary bacterial infections require prompt therapeutic interventions. This study highlights the critical need for personalized management strategies to mitigate complications and reduce mortality in this high-risk population.
20 December 2024 in Romanian Journal of Oral Rehabilitation
Pediatric diabetes presents significant challenges in dental treatment, requiring a tailored approach to minimize the risks associated with oral complications. Optimal glycemic control is fundamental before any intervention, and close collaboration with the diabetologist is essential to stabilize glucose levels. Local anesthesia should be used with caution, preferring solutions with low adrenaline concentrations, especially in patients with inadequate glycemic control. Dental treatment in children with diabetes involves a specialized approach due to the increased risks of oral complications and the peculiarities associated with this condition. Stable glycemic control is essential before any dental intervention, and collaboration with the diabetologist is crucial for adjusting the treatment. Local anesthesia should be administered with caution, using solutions with low adrenaline concentrations, especially in patients with unstable glycemic control. Educating patients and families about oral hygiene, diet, and the importance of regular visits to the dentist play a fundamental role in preventing dental complications. Children with diabetes are at increased risk of gum disease, such as gingivitis and periodontitis, so prompt management of these conditions through scaling and regular evaluations is vital. Rigorous oral hygiene should be encouraged to prevent infections and complications associated with compromised immune response. Interdisciplinary collaboration between dentists, diabetologists and other health professionals is essential for developing a coordinated and effective treatment plan.
20 December 2024 in Romanian Journal of Oral Rehabilitation
Salivary gland infections, called sialadenitis, are mainly caused by bacteria such as Staphylococcus aureus and Streptococcus species, but they can also result from mechanical blockages or viral infections. Complications of untreated or inadequately treated salivary gland infections can be severe, including the formation of abscesses, extension of the infection to neighboring structures, and permanent impairment of salivary gland functionality. In severe cases, surgery may be necessary to drain abscesses or remove obstructions such as salivary stones. Also, in the case of chronic infections, management may include long-term treatments and preventive measures, such as adequate hydration and maintaining rigorous oral hygiene. Integrated management of patients with systemic conditions, such as Sjogren's syndrome, is crucial for controlling symptoms and preventing complications. Antibiotics work through various mechanisms, including inhibiting bacterial cell wall synthesis, inhibiting protein synthesis, or interfering with essential bacterial functions. The effectiveness of antibiotic treatment is well documented in the medical literature, with clinical trials indicating a significant reduction in symptoms and prevention of severe complications when treatment is administered correctly. For example, bacteria such as Staphylococcus aureus and Streptococcus, commonly involved in salivary gland infections, respond well to antibiotic therapy, which reduces inflammation and associated pain.
Background: The COVID-19 pandemic has disproportionately affected the elderly population, with inflammation and impaired immune response being key drivers of disease progression. Clinicians require predictive models integrating immunological and inflammatory biomarkers to optimize risk stratification in this vulnerable group. Methods: We retrospectively analyzed 1429 elderly patients (aged >60 years) admitted with COVID-19 between March 2020 and August 2022. Demographic, clinical, and laboratory data were collected at admission. Correlation and regression analyses were performed to assess the prognostic significance of hematological and inflammatory markers. Results: Lymphopenia and neutrophilia were predominant findings, frequently associated with elevated C-reactive protein levels. Correlation analyses revealed significant associations between inflammatory markers and discharge status or death, while lymphocytes exerted a protective effect, reducing mortality risk by 14.4%. Notably, a higher platelet-large cell ratio (PLCR) was linked to increased mortality, suggesting an important contribution of thrombosis to severe COVID-19. Conclusions: Our findings indicate that immunological and inflammatory markers may serve as significant predictors of outcomes in elderly COVID-19 patients. While the predictive power of the model remains limited, these biomarkers can contribute to a better understanding of patient trajectories and may inform therapeutic strategies.
About Me
Hi! I am interested in gastroenterology, endoscopy procedures.
Hi! I am interested in gastroenterology, endoscopy procedures.